Five-item odorant test as an indicator of COVID-19 infection in a general population

Rahul A Patel, Sina J Torabi, David A Kasle, R Peter Manes, Rahul A Patel, Sina J Torabi, David A Kasle, R Peter Manes

Abstract

Purpose: To analyze the utility of a 5-item odorant test (U-Smell-It™) in determining COVID-19 status in COVID-19 polymerase chain reaction (PCR)-positive and -negative participants.

Methods: Symptoms, COVID-19 status, and 5-item odorant test results were collected from general population COVID-19 testing in Louisiana (n = 1042), and routine COVID-19 screening of healthcare workers in a nursing home in Florida (n = 278) (ClinicalTrials.gov Identifier: NCT04431908).

Results: In the general population COVID-19 testing site, a cutoff point of ≤2 (0, 1, or 2 correct answers out of 5) achieved sensitivity of 40.0% (95% CI: 26.4%-54.8%) and specificity of 89.2% (95% CI: 87.1%-91.1%) in detecting COVID-19 infection. Within this population, analysis of individuals with no self-reported loss of smell/taste and runny/stuffy nose resulted in sensitivity of 38.1% (95% CI: 18.1%-61.6%) and specificity of 92.3% (95% CI: 89.1%-93.4%), while analysis of individuals with self-reported loss of smell/taste and/or runny/stuffy nose resulted in sensitivity of 41.4% (95% CI: 23.5%-61.1%) and specificity of 82.4% (95% CI: 77.7%-86.5%).

Conclusions: The quick turnaround time, low cost, reduced resource requirement, and ease of administering odorant tests provide many advantages as an indicator sign to help flag a molecular diagnostic COVID-19 test with relatively high specificity. Our results suggest that this odorant testing for olfactory dysfunction may be a viable option in pre-screening COVID-19 infection. This tool has the potential to allow for continued monitoring and surveillance, while helping mitigate surges of COVID-19 variants. Further investigation is warranted to observe the extent to which odorant testing might be applied in a serial testing scenario.

Keywords: COVID-19; Odorant testing; Olfactory dysfunction; Rhinology.

Conflict of interest statement

The authors declare that there is no conflict of interest.

Copyright © 2022 Elsevier Inc. All rights reserved.

Figures

Fig. 1
Fig. 1
Number of odors correct on odorant test in general population COVID-19 testing A) PCR- individuals B) PCR+ individuals.
Fig. 2
Fig. 2
ROC curve for general population COVID-19 testing and routine HCW testing population.

References

    1. Shuren Jeffrey. United States Food and Drug Administration; 2021. Coronavirus (COVID-19) update: FDA takes steps to streamline path for COVID-19 screening tools, provides information to help groups establishing testing programs. Published March 16.
    1. Ward S., Lindsley A., Courter J., Assa’ad A. Clinical testing for COVID-19. J Allergy Clin Immunol. 2020;146(1):23–34. doi: 10.1016/j.jaci.2020.05.012.
    1. Moein S.T., Hashemian S.M., Mansourafshar B., Khorram-Tousi A., Tabarsi P., Doty R.L. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10(8):944–950. doi: 10.1002/alr.22587.
    1. Roland L.T., Gurrola J.G., Loftus P.A., Cheung S.W., Chang J.L. Smell and taste symptom-based predictive model for COVID-19 diagnosis. Int Forum Allergy Rhinol. 2020;10(7):832–838. doi: 10.1002/alr.22602.
    1. Doty R.L., Marcus A., Lee W.W. Development of the 12-item cross-cultural smell identification test (CC-SIT) Laryngoscope. 1996;106(3 Pt 1):353–356. doi: 10.1097/00005537-199603000-00021.
    1. Doty R.L., Shaman P., Kimmelman C.P., Dann M.S. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94(2 Pt 1):176–178. doi: 10.1288/00005537-198402000-00004.
    1. Hummel T., Sekinger B., Wolf S.R., Pauli E., Kobal G. “Sniffin” sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22(1):39–52. doi: 10.1093/chemse/22.1.39.
    1. Choudhury E.S. Influences of age and sex on a microencapsulated odor memory test. Chem Senses. 2003;28(9):799–805. doi: 10.1093/chemse/bjg072.
    1. Jackman A.H., Doty R.L. Utility of a three-item smell identification test in detecting olfactory dysfunction. Laryngoscope. 2005;115(12):2209–2212. doi: 10.1097/.
    1. Dalton P., Doty R.L., Murphy C., et al. Olfactory assessment using the NIH toolbox. Neurology. 2013;80(11 Suppl 3):S32–S36. doi: 10.1212/WNL.0b013e3182872eb4.
    1. Rawal S., Hoffman H.J., Honda M., Huedo-Medin T.B., Duffy V.B. The taste and smell protocol in the 2011–2014 US National Health and nutrition examination survey (NHANES): test-retest reliability and validity testing. Chemosens Percept. 2015;8(3):138–148. doi: 10.1007/s12078-015-9194-7.
    1. Liu D.T., Besser G., Lang M., et al. Odor mixtures in identification testing using sniffin’ sticks: the SSomix test. Sci Rep. 2020;10(1):8155. doi: 10.1038/s41598-020-65028-7.
    1. Duff K., McCaffrey R.J., Solomon G.S. The pocket smell test: successfully discriminating probable Alzheimer’s dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci. 2002;14(2):197–201. doi: 10.1176/jnp.14.2.197.
    1. Croy I., Zehner C., Larsson M., Zucco G.M., Hummel T. Test-retest reliability and validity of the sniffin’ TOM odor memory test. Chem Senses. 2015;40(3):173–179. doi: 10.1093/chemse/bju069.
    1. Kondo H., Matsuda T., Hashiba M., Baba S. A study of the relationship between the T&T olfactometer and the University of Pennsylvania Smell Identification Test in a Japanese population. Am J Rhinol. 1998;12(5):353–358. doi: 10.2500/105065898780182390.
    1. Eng John. Johns Hopkins University; 2014. ROC analysis: web-based calculator for ROC curves. Published March 19.
    1. Li C., Chen J., Qin G. Partial Youden index and its inferences. J Biopharm Stat. 2019;29(2):385–399. doi: 10.1080/10543406.2018.1535502.
    1. MedCalc Software Ltd . Diagnostic test evaluation calculator. MedCalc.
    1. MedCalc Software Ltd . Odds ratio calculator. MedCalc.
    1. Agyeman A.A., Chin K.L., Landersdorfer C.B., Liew D., Ofori-Asenso R. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc. 2020;95(8):1621–1631. doi: 10.1016/j.mayocp.2020.05.030.
    1. Lessa M.A., Cotta-Pereira S.M., Ferreira F.A., et al. 2021. The Usefulness of a Quantitative Olfactory Test for the Detection of COVID-19. Infectious Diseases (except HIV/AIDS)
    1. Paltiel A.D., Zheng A., Walensky R.P. COVID-19 screening strategies that permit the safe re-opening of college campuses. MedRxiv Prepr Serv Health Sci. 2020 doi: 10.1101/2020.07.06.20147702. Published online July 7.
    1. Biadsee A., Biadsee A., Kassem F., Dagan O., Masarwa S., Ormianer Z. Olfactory and oral manifestations of COVID-19: sex-related symptoms-a potential pathway to early diagnosis. Otolaryngol Head Neck Surg. 2020;163(4):722–728. doi: 10.1177/0194599820934380.
    1. Sayin İ., Yaşar K.K., Yazici Z.M. Taste and smell impairment in COVID-19: an AAO-HNS anosmia reporting tool-based comparative study. OtolaryngolHead Neck Surg. 2020;163(3):473–479. doi: 10.1177/0194599820931820.
    1. Speth M.M., Singer-Cornelius T., Oberle M., Gengler I., Brockmeier S.J., Sedaghat A.R. Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics. OtolaryngolHead Neck Surg. 2020;163(1):114–120. doi: 10.1177/0194599820929185.
    1. Mina M.J., Parker R., Larremore D.B. Rethinking Covid-19 test sensitivity — a strategy for containment. N Engl J Med. 2020;383(22) doi: 10.1056/NEJMp2025631.
    1. Bhattacharjee A.S., Joshi S.V., Naik S., Sangle S., Abraham N.M. Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers. EClinicalMedicine. 2020;28 doi: 10.1016/j.eclinm.2020.100575.
    1. Parma V., Hannum M.E., O’Leary M., et al. SCENTinel 1.0: development of a rapid test to screen for smell loss. Chem Senses. 2021 doi: 10.1093/chemse/bjab012. Published online March 27.
    1. World Health Organization (WHO) World Health Organization (WHO); 2020. Coronavirus Disease (COVID-19) Published November 10.
    1. Noh J.Y., Song J.Y., Yoon J.G., Seong H., Cheong H.J., Kim W.J. Safe hospital preparedness in the era of COVID-19: the Swiss cheese model. Int J Infect Dis. 2020;98:294–296. doi: 10.1016/j.ijid.2020.06.094.
    1. Rusetsky Y., Meytel I., Mokoyan Z., Fisenko A., Babayan A., Malyavina U. Smell status in children infected with SARS-CoV-2. The Laryngoscope. 2021 doi: 10.1002/lary.29403. Published online January 14.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe